Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections

Experimental Eye Research

Volumn 67, Issue 2, 1998, Pages 179-191

  Ocklind, Anette ^a  

^a PFIZER INC   (United States)

Author keywords

Ciliary muscle; Eyes; Human; Immunocytochemistry; Latanoprost; Metalloproteinases; Monkey; Plasmin; Prostaglandin F(2 ) extracellular matrix; Smooth muscle; Zymography

Indexed keywords

LATANOPROST; PROSTAGLANDIN F2 ALPHA;

AGED; AQUEOUS HUMOR FLOW; ARTICLE; CILIARY MUSCLE; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTRAOCULAR HYPERTENSION; PRIORITY JOURNAL;

EID: 0032144288     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1998.0508     Document Type: Article

References (45)

1. Alexander C. M., Werb Z. Extracellular matrix degradation. Cell biology of extracellular matrix. 1991;Plenum Press. p. 261-7.
2. Alm A., Villumsen J., Törnquist P., Mandahl A., Airaksinen J., Tuulonen A., Marsk A., Resul B., Stjernschantz J. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study. Ophthalmology. 100:1993;1312-1317.
3. Beckstead J. H. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J. Histochem. Cytochem. 42:1994;1127-1134.
4. Bill A. Basic physiology of the drainage of aqueous humour. Exp. Eye Res. 25 (Suppl.):1977;291-304.
5. Chamley-Campbell J., Campbell G. R., Ross R. The smooth muscle in cell culture. Physiol. Rev. 59:1979;1-67.
6. 2α. Invest. Ophthalmol. Vis. Sci. 29:1988;1428-1436.
7. 2α. Curr. Eye Res. 6:1987;1035-1044.
8. Hipps D. S., Hembry R. S., Docherty A. J. P., Reynolds J. J., Murphy G. Purification and characterization of human 72 kD Gelatinase (Type IV collagenase). Biol. Chem. Hoppe-Seyler. 372:1991;287-296.
9. Ishikawa T. Fine structure of the ciliary muscle. Invest. Ophthalmol. 1:1962;587-608.
10. Kleiner D. E., Stetler-Stevenson W. G. Quantitative zymography: detection of picogram quantities of gelatinases. Analyt. Biochem. 218:1994;325-329.
11. Laurent T. C., Fraser J. R. Hyaluronan. FASEB J. 6:1992;2397-2404.
12. Lawrence R., Hartman D. J., Sonenshein G. E. Transforming growth factor beta 1 stimulates type V collagen expression in bovine vascular smooth muscle cells. J. Biol. Chem. 269:1994;9603-9609.
13. Lindsey J. D., Kashiwagi K., Boyle D., Kashiwagi F., Firestein G. S., Weinreb R. Prostaglandin increase proMMP-1 and proMMP3- secretion by human ciliary smooth muscle cells. Curr. Eye Res. 15:1996;869-875.
14. Lindsey J. D., Kashiwagi K., Kashiwagi F., Weinreb R. N. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow. Surv. Ophthalmol. 41 (suppl 2):1977;S53-9.
15. Linsenmayer T. F. The collagens. Hay E. D. Cell biology of the extracellular matrix. 1992;7-44 Plenum Press.
16. 2α.
17. Lütjen-Drecoll E., Schenholm M., Tamm E., Tengblad A. Visualization of hyaluronic acid in the anterior segment of rabbit and monkey eyes. Exp. Eye Res. 51:1988b;55-63.
18. Mitchell P. G., Magna H. A., Reeves L. M., Lopresti-Morrow L. L., Yocum S. A., Rosner P. J., Geoghegan K. F., Hambor J. E. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97:1996;761-768.
19. Nagase H. Matrix metalloproteinases. A mini-review. Contrib. Nephrol. 107:1994;85-93.
20. Nagasubramanian S., Sheth G. P., Hitchings R. A., Stjernschantz J. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regiments. Ophthalmology. 100:1993;1305-1311.
21. 2α. Exp. Eye Res. 48:1989;707-716.
22. Ocklind A., Yousufzai S., Ghosh S., Coca-Prados M., Stjernschantz J., Abdel-Latif A. A. Immortalization of cat iris sphincter smooth muscle cells by SV40 virus: Growth, morphological, Biochemical and Pharmacological Characteristics. Exp. Eye Res. 61:1995;535-545.
23. 2α. Invest. Ophthalmol. Vis. Sci. 42:1996;716-726.
24. 2. Prostagland. Leukot. Essent. Fatty Acids. 57:1997;527-532.
25. Okada Y., Shinmei M., Tanaka O., Naka K., Kimura A., Nakanishi I., Bayliss M. T., Iwata K., Nagase H. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab. Invest. 66:1992;680-690.
26. Parums D. V., Cordell J. L., Micklem K., Heryet A. R., Gatter K. C., Mason D. J. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue section. J. Clin. Pathol. 43:1990;572-577.
27. Rawdanowicz T. J., Hampton A. L., Nagase H., Wooley D. E., Salomonsen L. A. Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1α and tumor necrosis factor. J. Clin. Endocrinol. Metab. 79:1994;530-536.
28. Rippelino J. A., Klinger M. M., Margolis R. V., Margolis R. K. The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue section: Application to chick embryo and rat brain. J. Histochem. Cytochem. 33:1985;1060-1066.
29. Rittig M., Lütjen-Drecoll E., Rauterberg J., Jander R., Mollenhauer J. Type VI collagen in human iris and ciliary body. Cell Tis. Res. 259:1990;305-312.
30. Rönnov-Jessen L., Celis J. E., Van Deurs B., Petersen O. W. A fibroblast-associated antigen: characterization in fibroblasts and immunoreactivity in smooth muscle differentiated stromal cells. J. Histochem. Cytochem. 40:1992;475-486.
31. Sappino A. P., Schurch W., Gabbiani G. Biology of disease. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab. Invest. 63:1990;144-161.
32. Sjöquist B., Almegård B., Khlifeh V., Alm A. The bioavailability of Xalatan® in the human eye. Invest. Ophthalmol. Vis. Sci. (Annual meeting). 38:1977;S248.
33. 2α. Adv. in Prostaglandin, Thromboxane, Leukotriene Res. 23:1995;513-518.
34. Svedberg B., Forsberg I. A morphological study on the effects of chronic administration of Latanoprost (LP) on the cilary muscle and trabecular meshwork in monkeys. Invest. Ophthalmol. Vis. Sci. (Annual meeting). 34:1993;S932.
35. 2α. Mech. Ageing Dev. 51:1990a;101-120.
36. 2α.
37. Tamm A., Baur A., Lütjen-Drecoll E. Synthesis of extracellular matrix components by human ciliary muscle cells in culture. Curr. Eye Res. 11:1992;333-341.
38. Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding proteins from cartilage. Biochem. Biophys. Acta. 578:1979;281-289.
39. Timpl R., Engel J. Type VI collagen. Mayne R., Burgeson R. E. Structure and function of collagen types. 1987;105-143 Academic Press.
40. Timpl R. Structure and biological activity of basement membrane proteins. Eur. J. Biochem. 180:1989;487-502.
41. Toris C. B., Camras C. B., Yablonski M. E., Brubaker R. F. Effect of Exogenous prostaglandins on aqueous humour dynamics and blood aqueous barrier function. Surv. Ophthalmol. 41 (suppl 2):1997;S69-76.
42. Uusitalo M., Kivela T. Development of cytoskeleton in neuroectodermally derived epithelial and muscle cells of the human eye. Invest. Ophthalmol. Vis. Sci. 36:1995;2584-2591.
43. Weinreb R. N., Lindsey J. D., Kashiwagi K. Prostaglandin treatment reduces collagen types I and III in cultures of human ciliary smooth muscle cells. Invest. Ophthalmol. Vis. Sci. (Annual meeting). 38:1997;S813.
44. Werb Z., Mainardi C. L., Vater C. A., Harris E. D., Jr. Endogenous activation of latent collagenase by rheutomatoid synovial cells. New Engl. J. Med. 296:1977;1017-1023.
45. Yamada K. M. Fibronectin and other cell interactive glycoproteins. Hay E. D. cell biology of the extracellular matrix. 1991;111-139 Plenum.